HNGE Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio—Forward 35.97
EPS (TTM)$-7.77-80.8% YoY
Profit margin-89.9%HEALTHCARE
Market cap$3.58BMid cap
Wall Street coverage
$57.53median target· current $37.56 (+53.2%)17 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- 35.97
- PEG ratio
- —
- P/B
- 19.67
- P/S (TTM)
- 6.09
- EV/EBITDA
- 226.55
Profitability & growth
- ROE (TTM)
- -132.9%
- Operating margin
- 16.0%
- Revenue growth YoY
- 45.6%
- Dividend yield
- —
- Beta
- —
Last earnings
Feb 10, 2026 · Estimate $0.43 · Reported $0.49
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Hinge Health, Inc.
Company profileHinge Health, Inc. develops health care software for joint and muscle health. The company is headquartered in San Francisco, California.
Classification
- Sector
- Healthcare
- Industry
- Health Information Services
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 455 MARKET STREET, SAN FRANCISCO, CA
- Fiscal year end
- December
- Latest quarter
- Dec 31, 2025
Market cap$3.58B
Shares outstanding$54.6M
52W high$62.18
52W low$0.00
Educational content · Not investment advice or recommendations
We're educators, not advisors. Your decisions are your own. Disclaimer
B
Agent
The AI built for clarity
I'm your AI thinking companion for the markets — I can help you explore and learn, but I'm not a financial advisor. Everything here is educational. Disclaimer
B
Agent